Q1 2019 Teva Pharmaceutical Industries Ltd Earnings Call Transcript
Good afternoon, ladies and gentlemen, and welcome to the Teva Pharmaceutical Industry's First Quarter 2019 Financial Results Call. (Operator Instructions) I must advise you that this conference is being recorded today, on Thursday, the 2nd of May 2019. I'd now like to hand the conference over to your first speaker today, Kevin Mannix, Senior Vice President, Investor Relations. Please go ahead.
Thank you, Jenny, and thank you, everyone, for joining us today to discuss Teva's First Quarter 2019 Financial Results. We hope you had an opportunity to review our earnings release, which was issued approximately 1 hour ago. A copy of this release as well as a copy of the slides being presented on this call can be found on our website at www.tevapharm.com as well as through our Teva Investor Relations app.
Please note that the discussion on today's call includes certain non-GAAP measures as defined by the SEC. Management uses both
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |